- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0068793

Radius Drug Private Limited
About Radius Drug Private Limited
Data last updated:
Radius Drug Private Limited is a private limited company based in Csa, Uttar Pradesh, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 10 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33111UP2010PTC041952.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shailesh Sinha and Rekha Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Csa, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.77 Lakh, a growth of 91% compared to the previous year. For the same year it recorded a net loss of ₹8.72 Lakh (net margin -15.1%) and EBITDA of -₹7.53 Lakh (EBITDA margin -13%).
Radius Drug Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0068793). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Radius Drug
Contact details
Radius Drug Private Limited's registered office is in Csa, Uttar Pradesh.
- Social Media
- Registered AddressPlot No.1 Arazi No. 111, Khyora Kachar Mainawati Marg, Csa, Uttar Pradesh, India – 208002
- IndustryHealthcare, Manufacturing, Medical & Surgical Equipment, Orthopedic Appliances, X-Ray Apparatus, Medical Appliances And Instruments
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Radius Drug is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Radius Drug Private Limited, buy the company report.
Financials of Radius Drug Private Limited
FY 2025 filings availableRadius Drug Private Limited reported revenue of ₹57.77 Lakh (up 91% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 91% in the latest year. EBITDA fell 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13% | ||||
| Net Profit Margin | -15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Radius Drug Private Limited, buy the company report.
Board of directors of Radius Drug Private Limited
Radius Drug has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh Sinha | Director | 10 Sep 2010 | 16 Years 1 Months | Current |
| Rekha Sinha | Director | 10 Sep 2010 | 16 Years 1 Months | Current |
Peer comparison
Radius Drug Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esaren Pharmaceuticals Private Limited | ₹57.81 Lakh (FY 2024) | 6.0% | Kanpur, Uttar Pradesh, India | |||
| Radius Drug Private Limitedthis company | ₹57.77 Lakh (FY 2025) | -₹8.72 Lakh | -15.1% | 91.0% | Csa, Uttar Pradesh, India | |
| Zatix Pharmaceuticals Private Limited | ₹57.7 Lakh (FY 2024) | 46.0% | New Delhi, Delhi, India | |||
| Beyondinfinite.Com Semiconductor Private Limited | ₹57.59 Lakh (FY 2024) | 61.0% | New Delhi, Delhi, India | |||
| Ariskon Pharma Private Limited | ₹57.57 Lakh (FY 2024) | 48.0% | New Delhi, Delhi, India |
To see the full peer comparison of Radius Drug Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Radius Drug Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Radius Drug Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Radius Drug Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Radius Drug Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Rekha Sinha was appointed as Director on 10 Sep 2010.
Frequently asked questions
Radius Drug is an active private limited company based in Csa, Uttar Pradesh, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 10 September 2010 (16+ years old) and is registered under CIN U33111UP2010PTC041952.
Radius Drug has 2 current directors:
- Shailesh Sinha - Director
- Rekha Sinha - Director
The latest financial statements of Radius Drug on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Radius Drug is U33111UP2010PTC041952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Radius Drug was incorporated on 10 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Radius Drug by revenue are Esaren Pharmaceuticals Private Limited, Zatix Pharmaceuticals Private Limited, Beyondinfinite.Com Semiconductor Private Limited, Ariskon Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rekha Sinha was appointed as Director on 10 Sep 2010. Shailesh Sinha was appointed as Director on 10 Sep 2010.
Yes, Radius Drug is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0068793).
The registered office of Radius Drug is at Plot No.1 Arazi No. 111, Khyora Kachar Mainawati Marg, Csa, Uttar Pradesh, India – 208002.
Radius Drug operates in the healthcare industry, in the manufacturing segment.
The compliance status of Radius Drug is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.